Immunohistochemical demonstration of nitric oxide synthase (NOS) in the normal rat pituitary gland, estrogen-induced rat pituitary tumor and human pituitary adenomas

Folia Histochemica et Cytobiologica

Volumn 41, Issue 2, 2003, Pages 87-90

  Pawlikowski, Marek ^a   Winczyk, Katarzyna ^a   Jaranowska, Maria ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Nitric oxide (NO); Nitric oxide synthase (NOS); Pituitary gland; Pituitary tumors

Indexed keywords

DIETHYLSTILBESTROL; ESTROGEN; ISOENZYME; NITRIC OXIDE SYNTHASE; POLYCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LOCALIZATION; EXPERIMENTAL MODEL; HUMAN; HUMAN TISSUE; HYPOPHYSIS; HYPOPHYSIS ADENOMA; HYPOPHYSIS CELL; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROVASCULARIZATION; NONHUMAN; PROLACTINOMA; RAT;

ANIMALIA;

EID: 0037247094     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ambs S, Bennett WP, Merriam WG, Ogunfusika MO, Oser SM, Khan MA, Jones RT, Harris CC (1998) Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53. Brit J Cancer 78: 233-239
2. Ambs S, Merriam WG, Bennet WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC (1998) Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression. Cancer Res 58: 334-341
3. Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA (1995) Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 55: 727-730
4. De Paepe B, Verstraeten VM, De Potter CR, Bullock GR (2002) Increased angiotensin II type 2 receptor density in hyperplasia, DCIS and invasive carcinoma of the breast is paralleled with increased iNOS expression. Histochem Cell Biol 117: 13-19
5. Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW (1995) Vasculature in non-tumorous hypophyses, pituitary adenomas and carcinomas: A quantitative morphologic study. Endocr Pathol 6: 115-124
6. Kunert-Radek J, Stepień H, Pawlikowski M (1994) Inhibition of pituitary cell proliferation by benzodiazepines in vitro. Neuroendocrinology 59: 92-96
7. Lewko B, Zoltowska A, Stepinski J, Kaminski M, Skokowski J, Roszkiewicz A, Moszkowska G (2001) Nitric oxide synthase type 1 expression in human lung cancer and its relation to p53. Med Sci Monit 7: 218-221
8. Lloyd RV, Jin L, Qian X, Zhang S, Scheithauer BW (1995) Nitric oxide synthase in the human pituitary gland. Am J Pathol 146: 86-94
9. Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2112
10. Palmer RMJ, Ferridge AG, Moncada S (1987) Nitric oxide accounts for the biological activity of endothelium derived relaxing factor. Nature 327: 524-526
11. Pawlikowski M, Pisarek H, Jaranowska M (1997) Immunocytochemical investigations on the vascularization of pituitary adenomas. Endocr Pathol 8: 189-193
12. Shi Q, La Paglia N, Emanuele NV, Emanuele MA (1998) Castration differentially regulates nitric oxide synthase in the hypothalamus and pituitary. Endocr Res 24: 29-54
13. Stepień H, Grochal M, Zielińska KW, Mucha S, Kunert-Radek J, Kulig A, Stawowy A, Pisarek H (1996) Inhibitory effects of fumagillin and TNP-470 on the function, morphology and angiogenesis of oestrogen-induced prolactinomas in Fischer 344 rats. J Endocrinol 150: 99-106
14. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S (1994) Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54: 1352-1354
15. Ueta Y, Levy A, Powell MP, Lightman SL, Kinoshita Y, Yokota A, Shibuya I, Yamashita H (1998) Neuronal nitric oxide synthase gene expression in human pituitary tumours: A possible association with somatotroph adenomas and growth hormone releasing hormone gene expression. Clin Endocrinol 49: 29-38